This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Pockros PJ (2006) Noninvasive markers of fibrosis in chronic hepatitis patients. J Clin Gastroenterol 40: 461–463
McGill DB et al. (1990) A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 99: 1396–1400
Poynard T et al. (2004) Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp Hepatol 3: 8–19
Fried MW et al. (2002) Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347: 975–982
Acknowledgements
The synopsis was written by Paul J Pockros, Head of the Gastroenterology and Hepatology Department, at the Scripps Clinic, La Jolla, CA, USA.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Nourani, S., Pockros, P. How should hepatitis C be managed in patients aged 65 years and older?. Nat Rev Gastroenterol Hepatol 4, 22–23 (2007). https://doi.org/10.1038/ncpgasthep0682
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpgasthep0682